HomeCompareSFSLF vs JNJ

SFSLF vs JNJ: Dividend Comparison 2026

SFSLF yields 2.76% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SFSLF wins by $47.5K in total portfolio value
10 years
SFSLF
SFSLF
● Live price
2.76%
Share price
$112.80
Annual div
$3.12
5Y div CAGR
39%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.8K
Annual income
$21,339.18
Full SFSLF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SFSLF vs JNJ

📍 SFSLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSFSLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SFSLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SFSLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SFSLF
Annual income on $10K today (after 15% tax)
$234.80/yr
After 10yr DRIP, annual income (after tax)
$18,138.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SFSLF beats the other by $14,152.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SFSLF + JNJ for your $10,000?

SFSLF: 50%JNJ: 50%
100% JNJ50/50100% SFSLF
Portfolio after 10yr
$54.0K
Annual income
$13,014.29/yr
Blended yield
24.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SFSLF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
7.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SFSLF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSFSLFJNJ
Forward yield2.76%2.13%
Annual dividend / share$3.12$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR39%28%
Portfolio after 10y$77.8K$30.3K
Annual income after 10y$21,339.18$4,689.40
Total dividends collected$51.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SFSLF vs JNJ ($10,000, DRIP)

YearSFSLF PortfolioSFSLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,084$383.97$10,592$272.30+$492.00SFSLF
2$12,413$552.86$11,289$357.73+$1.1KSFSLF
3$14,086$804.30$12,123$472.89+$2.0KSFSLF
4$16,258$1,185.69$13,141$629.86+$3.1KSFSLF
5$19,173$1,777.76$14,408$846.81+$4.8KSFSLF
6$23,239$2,723.62$16,021$1,151.60+$7.2KSFSLF
7$29,154$4,288.43$18,122$1,588.22+$11.0KSFSLF
8$38,184$6,988.95$20,930$2,228.20+$17.3KSFSLF
9$52,748$11,891.11$24,792$3,191.91+$28.0KSFSLF
10$77,780$21,339.18$30,274$4,689.40+$47.5KSFSLF

SFSLF vs JNJ: Complete Analysis 2026

SFSLFStock

SFS Group AG supplies mechanical fastening systems, assemblies, precision molded parts, and logistics solutions internationally. It offers airbag restraint systems; automation; bracket logic concept; brake systems; building technologies; clip nuts; communication technologies; components, assemblies, and complete devices; connections and reinforcements for timber construction; and domestic and kitchen appliances. The company also provides fasters for inserts; fastening and hinge technology for doors, windows, and glass facades; fastening system for the façade; furniture fittings; hand driving tools and wrenches; hard disk drives; inserts; interior plastics; life-saving fall protection; lifestyle electronics; mobile devices; sensors; seats and doors; connections and reinforcements for structural timber construction; tools, forest and garden equipment; wire and hypotubing; and window fittings. It offers its products to the aircraft, automotive, construction, electronics, medical, and other markets. SFS Group AG was founded in 1928 and is headquartered in Heerbrugg, Switzerland.

Full SFSLF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SFSLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SFSLF vs SCHDSFSLF vs JEPISFSLF vs OSFSLF vs KOSFSLF vs MAINSFSLF vs ABBVSFSLF vs MRKSFSLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.